FDx Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$593K Sell
2,424
-1,110
-31% -$259K 0.19% 83
2025
Q4
$731K Sell
3,534
-211
-6% -$41.7K 0.37% 41
2025
Q3
$707K Sell
3,745
-160
-4% -$27.4K 0.21% 77
2025
Q2
$596K Sell
3,905
-26
-0.7% -$4K 0.18% 84
2025
Q1
$652K Sell
3,931
-282
-7% -$44.1K 0.21% 74
2024
Q4
$609K Buy
4,213
+433
+11% +$67.1K 0.18% 83
2024
Q3
$613K Buy
3,780
+718
+23% +$114K 0.17% 89
2024
Q2
$448K Sell
3,062
-18
-0.6% -$2.68K 0.12% 108
2024
Q1
$487K Sell
3,080
-18,865
-86% -$3M 0.07% 207
2023
Q4
$3.44M Sell
21,945
-3,049
-12% -$468K 0.27% 93
2023
Q3
$3.89M Sell
24,994
-8,626
-26% -$1.42M 0.32% 81
2023
Q2
$5.57M Sell
33,620
-15,630
-32% -$2.52M 0.31% 86
2023
Q1
$8.7M Hold
49,250
0.38% 65
2022
Q4
$8.7M Sell
49,250
-1,171
-2% -$202K 0.38% 65
2022
Q3
$8.24M Buy
50,421
+153
+0.3% +$25.9K 0.37% 62
2022
Q2
$8.92M Sell
50,268
-897
-2% -$160K 0.34% 67
2022
Q1
$9.07M Buy
51,165
+5,036
+11% +$857K 0.31% 67
2021
Q4
$7.89M Buy
46,129
+7,394
+19% +$1.21M 0.22% 93
2021
Q3
$6.26M Buy
38,735
+2,711
+8% +$463K 0.2% 93
2021
Q2
$5.93M Buy
36,024
+1,992
+6% +$330K 0.2% 98
2021
Q1
$5.59M Sell
34,032
-5,414
-14% -$876K 0.21% 97
2020
Q4
$6.21M Sell
39,446
-14,531
-27% -$2.14M 0.26% 92
2020
Q3
$8.04M Buy
53,977
+5,068
+10% +$750K 0.38% 62
2020
Q2
$6.88M Sell
48,909
-1,869
-4% -$272K 0.36% 66
2020
Q1
$6.66M Buy
50,778
+2,921
+6% +$414K 0.43% 56
2019
Q4
$6.98M Buy
47,857
+8,312
+21% +$1.13M 0.39% 63
2019
Q3
$5.12M Sell
39,545
-22,119
-36% -$2.91M 0.35% 68
2019
Q2
$8.59M Buy
61,664
+1,943
+3% +$269K 0.34% 66
2019
Q1
$8.35M Buy
59,721
+15,125
+34% +$2.03M 0.34% 61
2018
Q4
$5.75M Sell
44,596
-32,829
-42% -$4.58M 0.47% 38
2018
Q3
$10.7M Buy
77,425
+5,391
+7% +$716K 0.4% 48
2018
Q2
$8.74M Sell
72,034
-22,679
-24% -$2.83M 0.32% 65
2018
Q1
$12.1M Sell
94,713
-3,449
-4% -$466K 0.36% 53
2017
Q4
$13.7M Sell
98,162
-40,837
-29% -$5.69M 0.37% 47
2017
Q3
$18.1M Buy
138,999
+2,901
+2% +$385K 0.5% 34
2017
Q2
$18M Sell
136,098
-3,422
-2% -$437K 0.53% 31
2017
Q1
$17.4M Sell
139,520
-25,434
-15% -$3.04M 0.53% 30
2016
Q4
$19M Buy
164,954
+81,273
+97% +$9.39M 0.55% 29
2016
Q3
$9.88M Buy
83,681
+2,640
+3% +$320K 0.41% 43
2016
Q2
$9.83M Buy
81,041
+7,841
+11% +$891K 0.44% 36
2016
Q1
$7.92M Buy
73,200
+2,299
+3% +$238K 0.36% 61
2015
Q4
$7.28M Buy
70,901
+26,418
+59% +$2.66M 0.33% 62
2015
Q3
$4.15M Sell
44,483
-5,719
-11% -$553K 0.36% 54
2015
Q2
$4.96M Buy
50,202
+202
+0.4% +$20.2K 0.25% 74
2015
Q1
$5.03M Sell
50,000
-2,242
-4% -$228K 0.11% 162
2014
Q4
$5.46M Sell
52,242
-12,066
-19% -$1.27M 0.33% 49
2014
Q3
$6.86M Buy
64,308
+4,183
+7% +$434K 0.44% 33
2014
Q2
$6.29M Buy
60,125
+23,706
+65% +$2.4M 0.41% 35
2014
Q1
$3.58M Buy
36,419
+13,469
+59% +$1.25M 0.3% 62
2013
Q4
$2.09M Buy
22,950
+1,655
+8% +$153K 0.21% 111
2013
Q3
$1.85M Buy
21,295
+3,312
+18% +$297K 0.22% 100
2013
Q2
$1.54M Buy
+17,983
New +$1.53M 0.2% 111

Other funds holding JNJ

FDx Advisors's JNJ Position: Q1 2026 in Review

FDx Advisors reduced its Johnson & Johnson (JNJ) stake by 31% in Q1 2026, selling an estimated $259K and leaving 2,424 shares worth $593K. The position accounts for 0.19% of the portfolio, ranked #83.

FDx Advisors first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $19M in Q4 2016. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • FDx Advisors held 2,424 shares of Johnson & Johnson worth $593K as of Q1 2026.
  • FDx Advisors sold 1,110 Johnson & Johnson shares in Q1 2026, an estimated $259K.
  • Johnson & Johnson made up 0.19% of FDx Advisors's portfolio in Q1 2026, its #83 holding.
  • FDx Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • FDx Advisors's Johnson & Johnson position peaked at $19M in Q4 2016.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on FDx Advisors's 13F filing for Q1 2026, filed 1 May 2026.